HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Narayan Shivapurkar Selected Research

Proglumide (Milid)

2/2022Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.
9/2021Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.
1/2021Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.
11/2018Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Narayan Shivapurkar Research Topics

Disease

22Neoplasms (Cancer)
09/2021 - 06/2002
6Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 01/2011
6Lung Neoplasms (Lung Cancer)
05/2014 - 01/2002
5Fibrosis (Cirrhosis)
09/2021 - 11/2018
3Carcinogenesis
09/2021 - 04/2003
3Neoplasm Metastasis (Metastasis)
09/2021 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
01/2021 - 02/2015
3Inflammation (Inflammations)
01/2021 - 01/2019
3Breast Neoplasms (Breast Cancer)
10/2017 - 04/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 06/2002
2Non-alcoholic Fatty Liver Disease
02/2022 - 01/2020
2Fatigue
04/2018 - 11/2017
2Chronic Disease (Chronic Diseases)
04/2018 - 11/2017
2Disease Progression
10/2017 - 03/2016
2Leukemia
03/2008 - 01/2005
2Lymphoma (Lymphomas)
03/2008 - 01/2005
2Malignant Mesothelioma
04/2006 - 02/2005
2Mesothelioma
04/2006 - 06/2002
2Adenoma (Adenomas)
02/2006 - 06/2002
1Liver Neoplasms (Liver Cancer)
01/2021
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2020
1Obesity
11/2018
1Adenocarcinoma
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2014
1Pancreatic Diseases (Pancreatic Disease)
01/2011
1Virus Diseases (Viral Diseases)
03/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2006
1Prostatic Neoplasms (Prostate Cancer)
12/2006
1Paraproteinemias (Monoclonal Gammopathy)
01/2005
1Multiple Myeloma
01/2005
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2002

Drug/Important Bio-Agent (IBA)

9MicroRNAs (MicroRNA)IBA
09/2021 - 01/2011
5Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
09/2021 - 01/2018
5DNA (Deoxyribonucleic Acid)IBA
05/2014 - 04/2006
4Proglumide (Milid)IBA
02/2022 - 11/2018
4CytokinesIBA
01/2021 - 01/2005
4Peptides (Polypeptides)IBA
01/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
09/2021 - 03/2007
3Messenger RNA (mRNA)IBA
01/2019 - 02/2005
3Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2005
3Pharmaceutical PreparationsIBA
10/2017 - 04/2003
3Caspase 8 (Caspase-8)IBA
12/2002 - 01/2002
2GemcitabineFDA Link
09/2021 - 01/2011
2Cholecystokinin (Pancreozymin)IBA
01/2021 - 11/2018
2GastrinsIBA
01/2019 - 01/2018
2Biological ProductsIBA
03/2008 - 12/2006
2AsbestosIBA
02/2005 - 06/2002
2Death Domain ReceptorsIBA
12/2002 - 10/2002
1ArginaseIBA
09/2021
1ChemokinesIBA
01/2021
1Sirolimus (Rapamycin)FDA Link
01/2020
1Calcium-Binding ProteinsIBA
01/2020
1Transaminases (Aminotransferases)IBA
01/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020
1Collagen Type IV (Type IV Collagen)IBA
01/2020
114-3-3 Proteins (14-3-3 Protein)IBA
01/2020
1Beclin-1IBA
01/2020
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2020
1Lipocalin-2IBA
01/2020
1AMP-Activated Protein KinasesIBA
01/2020
1Protein Kinases (Protein Kinase)IBA
01/2019
1Metalloproteases (Metalloproteinases)IBA
11/2018
1FatsIBA
11/2018
1Dietary Fats (Dietary Fat)IBA
11/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1MicellesIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
10/2017
1Hormones (Hormone)IBA
10/2017
1Aromatase InhibitorsIBA
10/2017
1Cell-Free Nucleic AcidsIBA
10/2017
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
10/2017
1Circulating MicroRNAIBA
03/2016
1Lapatinib (GW572016)FDA Link
03/2016
1Capecitabine (Xeloda)FDA Link
03/2016
1Fluorouracil (Carac)FDA LinkGeneric
03/2016
1SpectrinIBA
02/2015
1kallistatinIBA
02/2015
1SmokeIBA
03/2008
1Monomeric GTP-Binding ProteinsIBA
04/2007
1DecitabineFDA Link
12/2006
1Tumor Viral Antigens (Large T Antigen)IBA
04/2006
1Viral ProteinsIBA
04/2006
1Calcibiotic Root Canal SealerIBA
02/2006
1Mitochondrial DNA (mtDNA)IBA
10/2005
1Indicators and Reagents (Reagents)IBA
05/2004
1TNF-Related Apoptosis-Inducing LigandIBA
05/2004
1Death-Associated Protein KinasesIBA
08/2003
1Histones (Histone)IBA
08/2003
1LigandsIBA
12/2002
1Cadherins (E-Cadherin)IBA
06/2002
1LuciferasesIBA
06/2002
1H-cadherin (T-cadherin)IBA
06/2002
1hydrogen sulfite (bisulfite)IBA
06/2002

Therapy/Procedure

9Therapeutics
09/2021 - 04/2003
3Drug Therapy (Chemotherapy)
09/2021 - 04/2003
1Lasers (Laser)
01/2019